To view this email as a web page, click here.

 
DME Resource Center
 
Diabetic eye disease sees advances, but questions remain
Despite myriad advances for the treatment of diabetic eye disease, retinal specialists still have an ongoing therapy challenge. Rishi P. Singh, MD, explains why.
Continue
 
Two drugs better than one in DME therapy?
Whereas most studies investigate one drug in each arm, "this approach is unique," says Charles C. Wykoff, MD, PhD. He shares more about how this combination therapy fared compared with monotherapy alone.
Learn more
ADVERTISEMENT
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.